Anesthesiology Doctors in Salem, NJ Accepting Medicare

5 Anesthesiology doctors found. Showing 1 - 5

Dr. Brandon Keefe Pierce, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 310 Woodstown Rd, Salem, NJ 08079 Phone: 856-935-1000

Dr. John Corbin, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 Woodstown Rd, Salem, NJ 08079 Phone: 856-935-1000

Dr. Veneranda Cagande, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 310 Woodtown Rd, Salem, NJ 08079 Phone: 856-339-6052    Fax: 856-935-0962

Dr. Chi H Pham, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 310 Woodstown Rd, Salem, NJ 08079 Phone: 856-339-6021

Primo Maestrado, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 Woodstown Rd, Salem, NJ 08079 Phone: 856-339-6021    Fax: 856-935-5420

News Archive

AbleNet announces acquisition of TeleConcepts

AbleNet announced today the acquisition of TeleConcepts, a company with over 25 years experience and success with direct telephone outreach. Their primary customer base includes professionals who serve the hard of hearing market. AbleNet sees this as an important part of meeting the full needs of individuals with disabilities.

Scientists unlock secrets of gene regulatory networks

A quartet of studies by researchers at the California Institute of Technology (Caltech) highlight a special feature on gene regulatory networks recently published in the Proceedings of the National Academy of Sciences ( PNAS ).

IRX Therapeutics and Japan's NCRC collaborate to evaluate peptide-based cancer vaccines

IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan's National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen, clinical trial design and technical support. This is the first collaboration of its kind between the NCRC and a U.S.-based biotechnology firm.

Rare genetic mutation could improve outcomes in NSCLC patients with brain metastases

Most patients with non-small cell lung cancer (NSCLC) that has metastasized to the brain have a dire prognosis. But Yale researchers have identified a subset of those patients with a rare genetic mutation who are living significantly longer than patients without the mutation.

Read more Medical News

› Verified 8 days ago